Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEFLUNOMIDE vs LENALIDOMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEFLUNOMIDE vs LENALIDOMIDE: Safety Overview

Metric LEFLUNOMIDE LENALIDOMIDE
Total FAERS Reports 56,539 349,955
Deaths Reported 5,283 35,942
Death Rate 9.3% 10.3%
Hospitalizations 13,923 86,495
Average Patient Age 51.3 yrs 69.9 yrs
% Female Patients 87.3% 50.0%
FDA Approval Date Apr 24, 2019 Aug 3, 2023
Manufacturer Alembic Pharmaceuticals Inc. Padagis US LLC
Route ORAL ORAL
Marketing Status Prescription Prescription